Table 1 Diagnosis criteria of metabolic syndrome used in the current study
ATP III criteria | IDF criteria | Revised ATP III criteria | CDS criteria | |
|---|---|---|---|---|
To be identified as MetS | Any three or more of the following five components | Central obesity plus any two other factors | Any three or more of the following five components | Any three or more of the following five components |
Central obesity (waist circumference) | ||||
Men | >102 cm | ≧90 cm for Chinese men | ≧90 cm for Asian men | ≧90 cm |
Women | >88 cm | ≧80 cm for Chinese women | ≧80 cm for Asian women | ≧85 cm |
Elevated TG | ≧1.70 mmol/L (150 mg/dL) | ≧1.70 mmol/L (150 mg/dL) mg/dL or specific treatment for this lipid abnormality | ≧1.70 mmol/L (150 mg/dL) or drug treatment for elevated TG | ≧1.70 mmol/L(150 mg/dL) |
Low HDL-C | ||||
Men | <1.04 mmol/L (40 mg/dL) | <1.04 mmol/L (40 mg/dL) in males or specific treatment for this lipid abnormality | <1.04 mmol/L (40 mg/dL) in men or drug treatment for reduced HDL-C | <1.04 mmol/L(40 mg/dL) |
Women | <1.29 mmol/L (50 mg/dL) | <1.29 mmol/L (50 mg/dL) in females or specific treatment for this lipid abnormality | <1.29 mmol/L (50 mg/dL) in women or drug treatment for reduced HDL-C | <1.04 mmol/L(40 mg/dL) |
Elevated BP | ≧130/85 mmHg | SBP ≧130 or DBP ≧85 mmHg, or treatment of previously diagnosed hypertension | ≧130 mmHg SBP or ≧85 mmHg DBP or on antihypertensive drug treatment in a patient with a history of hypertension | SBP ≧130 or DBP ≧85 mmHg, previously diagnosed hypertension |
Elevated FPG | ≧6.1 mmol/L (110 mg/dL) | ≧5.6 mmol/L (100 mg/dL), or previously diagnosed type 2 diabetes | ≧5.6 mmol/L (100 mg/dL) or drug treatment for elevated glucose | ≧6.1 mmol/L, 2 h plasma glucose ≧7.8 mmol/L, or previously diagnosed diabetes |